...

首页> 外文期刊>Obstetrical and gynecological survey >Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome EDITORIAL COMMENT

【24h】

Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome EDITORIAL COMMENT

机译：辅助概念的精确药物：膜蛋白A5M2单倍型的多中心观察治疗队列研究，作为改善妊娠结局的抗血栓处理的生物标志物编辑评论

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Obstetrical and gynecological survey》 |2018年第9期|共2页
作者
Keefe David;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类妇产科学;
关键词

相似文献

外文文献

1. Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome EDITORIAL COMMENT [J] . Keefe David Obstetrical and gynecological survey . 2018,第9期

机译：辅助概念的精确药物：膜蛋白A5M2单倍型的多中心观察治疗队列研究，作为改善妊娠结局的抗血栓处理的生物标志物编辑评论
2. Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome EDITORIAL COMMENT [J] . Keefe David Obstetrical and gynecological survey . 2018,第9期

机译：辅助概念的精确药物：膜蛋白A5M2单倍型的多中心观察治疗队列研究，作为改善妊娠结局的抗血栓处理的生物标志物编辑评论
3. Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome [J] . Simon Fishel, Deborah Baker, Janine Elson, EBioMedicine . 2016,第2期

机译：辅助概念中的精准医学：膜联蛋白A5 M2单倍型作为抗血栓治疗以改善妊娠结局的生物标志物的多中心观察治疗队列研究
4. Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305] [O] . Simon Fishel, Deborah Baker, Janine Elson, 2014

机译：“辅助概念中的精准医学：膜联蛋白A5 M2单倍型作为抗栓剂治疗以改善妊娠结局的生物标志物的多中心观察治疗队列研究”更正[EBioMedicine 10（2016）299-305]
5. Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305] [O] . Simon Fishel, Deborah Baker, Janine Elson, 2016

机译：“辅助概念中的精确医学：多中心观察治疗队列研究annexin a5 m2单倍型作为抗血栓治疗改善妊娠结局的生物标志物”的更正“[EBiomedicine 10（2016）299-305]

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号